At a glance
ClinicalIndex Comparison RecordN/ACompleted· 84 enrolled
Drug / intervention
Remdesivirdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections.
In Brief
An observational study evaluating Remdesivir for COVID-19. Completed, enrolled 84 participants across 1 site.
Detailed Summary
This study is a retrospective cohort trial to assess the efficacy of remdesivir in hospitalized adult patients diagnosed with COVID-19. The study is a multicenter trial which will be carried out on different sites in France. This trial is retrospective and will analyze the data collected during treatment.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19
CountriesFrance
CollaboratorsURC-CIC Paris Descartes Necker Cochin
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedApr 2020
Enrollment StartMay 2020
Primary CompletionJun 2020
TodayJul 2026
First PostedApr 28, 2020
Enrollment StartMay 5, 2020
Primary CompletionJun 12, 2020
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 6.2 years ago
Interventions
Remdesivirdrug
Compassionate provision